Live-cell imaging of p53 interactions using a novel Venus-based bimolecular fluorescence complementation system

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• The tumor suppressor protein p53 regulates critical cellular processes like cell cycle arrest and apoptosis.
• Dysfunctional p53 is implicated in various diseases, including cancer and neurodegenerative disorders.
• Targeting the interaction between p53 and its inhibitor Mdm2 is a promising therapeutic strategy.

Purpose of the Study:

• To develop and validate a Venus-based bimolecular fluorescence complementation (BiFC) system for screening p53 interaction modulators.
• To identify novel compounds that modulate p53-p53 and p53-Mdm2 interactions in live mammalian cells.

Main Methods:

• Development of a Venus-based BiFC assay for visualizing protein-protein interactions in real-time.
• Validation of the BiFC system using nutlin-3, a known inhibitor of p53-Mdm2 interaction.
• Screening a library of 33 protein phosphatase inhibitors for modulators of p53-Mdm2 complex formation.

Main Results:

• The BiFC assay demonstrated specificity, with nutlin-3 reducing the BiFC signal, correlating with increased Puma transactivation, PARP cleavage, and cell death.
• The study successfully identified potential modulators of p53-Mdm2 complex formation from the screened chemical library.
• The developed BiFC system provides a robust and direct method for identifying novel therapeutic targets.

Conclusions:

• The Venus-based BiFC system serves as a powerful tool for discovering modulators of p53 interactions.
• This approach offers a viable alternative to traditional drug discovery methods for p53-related pathologies.
• Identification of new modulators can enhance the efficacy of existing anti-tumor therapies.